MarketCap
Facebook
X
TelegramFluidigm Corporation EV/EBITDA Ratio 2011-2025 | FLDM
Annual EV/EBITDA Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -13.6 | -8.18 | -13.2 | -8.88 | -6.06 | -9.45 | -45.1 | -74.2 | -19 | -18 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.06 | -74.2 | -21.6 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 38.63 | - | $ 1.07 B |  USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 226.33 | - | $ 165 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.89 | - | $ 337 M |  Israel |
 |
DexCom
DXCM
|
39.5 | $ 66.96 | - | $ 25.8 B | USA |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 16.97 | - | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 15.75 | - | $ 169 M |  China |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 27.14 | 0.3 % | $ 821 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.62 | - | $ 2.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 222.26 | - | $ 40.3 B | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 393.64 | - | $ 29.6 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 7.21 | - | $ 653 M | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
-33.5 | $ 11.85 | - | $ 1.5 B | USA |
 |
Neogen Corporation
NEOG
|
40.3 | $ 6.86 | - | $ 1.49 B | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 20.56 | - | $ 1.11 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 105.25 | - | $ 4.15 B | USA |
 |
Pacific Biosciences of California
PACB
|
-23.8 | $ 2.12 | - | $ 538 M | USA |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 3.58 | - | $ 114 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 101.5 | - | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
3.62 | $ 0.34 | - | $ 9.98 M | USA |
 |
Precipio
PRPO
|
-1.8 | $ 24.97 | 0.06 % | $ 32.4 M | USA |
 |
Quidel Corporation
QDEL
|
9.16 | $ 28.8 | - | $ 1.21 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | $ 45.22 | - | $ 10.1 B |  Niderland |
 |
Guardant Health
GH
|
-28.8 | $ 102.07 | - | $ 12.5 B | USA |
 |
Sotera Health Company
SHC
|
24.8 | $ 16.83 | - | $ 4.76 B | USA |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Soleno Therapeutics
SLNO
|
0.12 | $ 52.0 | - | $ 2.09 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 26.62 | - | $ 20 B | Niderland |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Thermo Fisher Scientific
TMO
|
19.3 | $ 572.28 | 0.08 % | $ 219 B | USA |
 |
Trinity Biotech plc
TRIB
|
12.6 | $ 1.07 | - | $ 61.9 M |  Irlanda |
 |
Illumina
ILMN
|
70.5 | $ 134.87 | - | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
22 | $ 193.03 | 0.03 % | $ 9.92 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-23.6 | $ 30.93 | - | $ 1.85 B | USA |
 |
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 182.56 | - | $ 20.3 B | USA |
|
Biodesix
BDSX
|
-4.25 | $ 7.85 | - | $ 1.02 B | USA |